How to Justify an Innovation Center to Your Board

Executive presenting an innovation centre case to a board

Innovation cases fail in board meetings for a predictable reason: they are presented as investment cases with projected returns, and every experienced board member knows those projections are unreliable. Presenting a five year revenue figure for work whose entire purpose is to answer questions you cannot currently answer signals either optimism or unfamiliarity, and neither helps.

Boards do fund exploratory work. They fund it when the downside is bounded, the strategic question is real, the commitment is staged, and the person asking has been honest about what could go wrong. None of those require a projection.

This guide sets out how to structure the case, what to include, what to leave out, and how to handle the questions that come back.

Key points

Lead with the question, not the answer

The strongest opening is a strategic question the company cannot currently answer and needs to. Something specific: whether a category of customers can be served profitably at a tenth of the current cost to serve, whether a capability a competitor has demonstrated is reproducible, whether a technology shift makes part of the current model obsolete.

This works because it is true, because it is verifiable, and because it reframes the request. You are not asking the board to believe a projection. You are asking it to agree that a question matters and that answering it is worth a bounded amount of money.

The test of a good question is that both possible answers are valuable. If the answer is yes, you have found something. If the answer is no, you have avoided committing to something that would not have worked. A question where only one answer has value is usually a proposal in disguise.

You are not asking the board to believe a projection. You are asking it to agree that a question matters and is worth a bounded amount of money to answer.

Bound the downside explicitly

This is the part boards are actually evaluating, and most innovation cases barely address it. The relevant questions are what the maximum exposure is, how quickly it can be stopped, and what is lost if it is.

A well structured case answers all three before being asked. Annual cost is capped and stated. There are defined decision points at which the programme can be stopped. Exit cost is low, meaning short notice periods, no long leases and no large capital commitment. And the fallback position is unchanged, meaning the company is no worse off than if it had never started.

A small senior team in a market with reasonable notice periods, no facility commitment and no capital expenditure is a genuinely bounded commitment, and saying so plainly is more persuasive than any upside case.

What the board asks Weak answer Strong answer
What does this cost? It depends on scope A capped annual figure, stated
What is the return? A five year revenue projection An answer to a question that changes a decision
When do we know? It is a long term investment Named decision points at 6, 12 and 18 months
What if it fails? It will not Here is the cost, here is what we learn, here is the fallback
Can we stop? It would be a setback Yes, at any decision point, at a stated cost
Who runs it? A team will be recruited A named sponsor and a named centre lead
How do we use what works? It will transfer A named owner in the business has agreed to receive it

The last row is where most cases are weakest and where the eventual failure usually originates.

Stage the commitment

Asking for a three year commitment invites a three year level of scrutiny, and the case will not survive it because nothing in exploratory work can be forecast at that horizon. Asking for a first stage with a defined decision point invites a much smaller decision.

Staging also aligns with how the work actually proceeds. The first stage establishes the team and answers the first question. The second widens the portfolio if the first produced something. The third institutionalises it. Each stage has an explicit decision, and the board retains the ability to stop at each one.

This is not a technique for slipping a large commitment past a board in pieces, and it should not be presented as one. Be explicit that later stages exist and will require their own approval. Boards respond well to a plan that shows the whole path and asks only for the first step.

01
Stage 1, months 1 to 9

Establish and answer one question

Small senior team, one strategic question, capped budget. Decision point at month nine: did we get an answer, and was the answer useful?

02
Stage 2, months 10 to 24

Widen the portfolio

If stage one produced value, expand to several bets with portfolio governance. Decision point at month twenty four on adopted outcomes.

03
Stage 3, year 3 onward

Institutionalise

Permanent allocation, established gates, proven transfer route. This is the point at which it becomes a standing capability rather than a programme.

04
At every stage

Preserve the ability to stop

State the exit cost at each point. A commitment that can be stopped is much easier to approve than one that cannot.

State the failure conditions yourself

This is the single most effective technique available and the one most people avoid. Say plainly what would have to be true for this to have been the wrong decision.

Name them specifically: if we cannot hire at the seniority required, if the questions we choose turn out not to matter, if the business has no capacity to adopt what we produce, if the sponsor leaves and nobody replaces them. Each of these is a real risk and each has a mitigation, and presenting them yourself demonstrates that you have thought about the proposal as a decision rather than as a request.

Boards are unusually good at detecting when a risk section has been sanitised. A case with no failure conditions reads as a case that has not been stress tested, and the first question will be the one you left out.

Leadership team discussing an innovation mandate and its adoption route
Name the receiving owner before you ask for the money. Unadopted innovation is the standard failure.

Name the adoption route

Most innovation centres are not closed because they invented nothing. They are closed because nothing they invented was ever used, and the board reasonably concluded the spending produced no effect.

Address this in the case rather than leaving it as an implementation detail. Name the owner in the core business who will receive successful work, confirm they have agreed, and state that productionisation is funded separately so the centre does not have to choose between exploring and industrialising.

This single element differentiates a case that has been thought through from one that has been assembled. It also makes the eventual outcome far more likely to be positive, which matters more than winning the meeting.

What to leave out

Several standard inclusions actively weaken an innovation case, mostly because they invite scrutiny the underlying work cannot survive.

Handling the questions that come back

Three questions come back almost every time, and each has a good answer that most people do not give.

Because the seniority required is not available in our home market within the timeframe, or not at a price we can commit to. This is an access argument, not a cost argument, and it is more persuasive.

Because the capability should stay with us. A consultancy can answer the question and will take the understanding with it. If we expect to keep making decisions in this area, we need to hold the knowledge.

Something specific changed: a competitor moved, a technology became viable, a cost structure shifted, a regulation is coming. If nothing changed, the honest answer is that this could wait, and saying so preserves credibility for when it cannot.

We spend the capped amount, we learn something specific, and we are no worse positioned than today. Then name the failure conditions before anyone else does.

Bounded downside beats projected upside,Boards approve exploratory work when the maximum loss is known, the commitment is staged and the person asking has been honest about what could go wrong. An upside projection does none of that and invites a debate about a number you cannot defend.

Frequently asked questions

Should we include financial projections at all?

Include the cost, which is knowable, and avoid projecting the return, which is not. If a value figure is required, express it as the value of the decision the answer would inform rather than as revenue from a product that does not exist.

How much should we ask for?

Enough that the work is real and little enough that failure is affordable. A small senior team for the first stage is usually the right size. Asking for a large amount invites scrutiny the work cannot survive at this stage.

What if the board wants a business case with a return?

Reframe it around the decision rather than the product. What would the company do differently if the answer were yes, and what is that worth? That is a defensible number, unlike a revenue projection for something that does not exist yet.

How do we handle a board member who has seen innovation programmes fail?

Take it seriously and use it. Ask what went wrong and address those specific failure modes in the case. Most previous failures were adoption failures or unbounded commitments, and both are addressable in the structure of your proposal.

Should we name the strategic question publicly in the board pack?

Yes, and be specific. A vague framing such as exploring emerging technology cannot be assessed, which means the board is being asked to approve on trust alone. A specific question can be judged on whether it matters, which is a far better position.

Who should present the case?

The executive sponsor, not the prospective centre lead. The board is assessing whether a senior person is willing to attach their credibility to it, and that signal is a substantial part of what is being evaluated.

What if we cannot name an adoption owner yet?

Then the case is not ready. If no one in the business will commit to receiving successful work, the programme will produce prototypes nobody uses. Finding that out before asking for money is a good outcome, not a setback.

How long should the board pack be?

Short. The question, the bounded cost, the stages and decision points, the failure conditions and the adoption route. Length tends to correlate with weakness in innovation cases, because detail is used to substitute for a clear question.

Sources & further reading

Make the case defensible before you make it

Hexominds helps structure innovation mandates with bounded downside, staged commitment and a clear adoption route, which is what boards actually approve.

Home
Solutions
SaaS & Technology Healthcare FinTech Hospitality & Travel Tech Retail & E-Commerce
Insights
What Is a Nano GCC? The Future of GCCs AI Talent in India Product Engineering Value Generation Framework True-Up Cost Methodology All Insights
How It Works
The GCC Journey GCC Launch Roadmap Why India Readiness Assessment About Hexominds
Services
Legal & Compliance HR & Workforce Infrastructure & IT Agentic AI Innovation All Services Our Locations Enquire Now